IndiaTickerLatest filing: Structural Digital Database - Indo Us Biotech Limited
ObservedCompany dossier
Indo Us Bio-Tech
NSE:INDOUS · ISIN INE250Z01010
- Close
- ₹84.76 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Indo Us Bio-Tech
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 30 Sept 2024 · revenue ₹22.2 Cr · PAT ₹4.4 Cr.
Exchange XBRLLatest ownership: promoter group 68.29% and public 31.71% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Structural Digital Database - Indo Us Biotech Limited
NSE · exchange filing
Observed
Source filing Indo Us Bio-Tech Ltd - 541304 - Revised Outcome Of The Board Meeting Held On 10 July 2026. Reconstitution Of Committees.
BSE · exchange filing
Observed
Source filing Indo Us Bio-Tech Ltd - 541304 - Revised: Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015. Ref.: Mail From [email protected] On 13.07.2026 Subject: Resignation Of Statutory Auditor And Appointment Of New Statutory Auditor. Resubmitting The Details As Per Attached SEBI Circular Dated October 18, 2019, Through BSE Listing Centre.
BSE · exchange filing
Observed
Archived filing General Updates - Indo Us Biotech Limited
NSE · financial results
Reported financials
Full financials →30 Sept 2024
- Revenue from operations
- ₹22.2 Cr
- Profit after tax
- ₹4.4 Cr
- EPS
- ₹2.16
Observed NSE structured filing · Non-Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 68.29%
- Public
- 31.71%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL